Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021
View abstract on PubMed
Summary
This summary is machine-generated.Most ovarian cancer patients do not receive maintenance therapy (MT) after chemotherapy. Factors like age, comorbidities, and location influence MT use, impacting patient decisions and outcomes.
Area Of Science
- Oncology
- Real-world evidence
- Cancer treatment trends
Background
- Maintenance therapy (MT), including poly(ADP-ribose) polymerase inhibitors (PARPi) and bevacizumab, is a key treatment strategy for ovarian cancer.
- Understanding real-world utilization patterns of MT following platinum-based chemotherapy is crucial for optimizing patient care.
Purpose Of The Study
- To assess the real-world trends in the utilization of maintenance therapy (MT) among U.S. ovarian cancer patients post-platinum-based chemotherapy.
- To identify demographic and clinical factors associated with MT use and evaluate its impact on patient outcomes.
Main Methods
- Analysis of de-identified Medicare and commercial claims data (January 2010–March 2021).
- Inclusion of 6339 ovarian cancer patients who received platinum-based chemotherapy and MT.
- Utilized multivariable logistic and Cox proportional hazards regression to analyze MT use and associated factors.
Main Results
- Only 31.5% of patients received MT; bevacizumab and PARPi use increased significantly from 2017-2020.
- Higher comorbidity index (OR: 1.46) and treatment in the South (for PARPi) were associated with MT use.
- Bevacizumab use, alone or with PARPi, was linked to a higher risk of death (HR: 2.02 and 1.66, respectively).
Conclusions
- The majority of ovarian cancer patients do not receive maintenance therapy after chemotherapy.
- Patient age, comorbidity status, and geographic region significantly influence MT utilization.
- Further research is needed to understand real-world outcomes and support informed, value-based treatment decisions.
Related Concept Videos
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Current trends in nursing include:
The changes that have shaped the profession.
Guided legislation.
The functioning of the present healthcare system.
With an increase in the aging population worldwide, it is crucial to train nurses from all healthcare settings to identify approaches that enable older adults to live independently. Nurses also provide essential care and education to manage multiple chronic conditions and ensure the elderly in long-term care receive optimal care and...
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

